Kathleen Iacocca and Yao Zhao discuss why direct supply chain models can be more sustainable than resell models in the long run and whether they can be implemented in the US.
Kathleen Iacocca, Yao Zhao
Advertisement
Kathleen Iacocca, Assistant professor, Dept. of Operations & Information Management, University of Scranton, Kathleen.iacocca@scranton.edu; Yao Zhao, Associate professor, Dept. of Supply Chain Management and Marketing Sciences, Rutgers Business ,yaozhao@andromeda.rutgers.edu
Articles by Kathleen Iacocca, Yao Zhao
Advertisement
Latest Updated Articles
Resell vs. Direct Models: US Branded Drug Distribution in the FuturePublished: July 17th 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Novo Nordisk Sends Amended Acquisition Proposal to Metsera
2
MFN Executive Order Webinar: Inside Trump’s Drug Price Plan
3
Pharmaceutical Executive Daily: Kimberly-Clark’s $48.7 Billion Acquisition of Kenvue
4
Cencora Reveals $1 Billion Investment Plan Enhancing US-Based Distribution Network
5
